Atlas Trials

Nabriva Therapeutics AG

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Nabriva Therapeutics AG

RecordFirmDate
Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis (NCT05225805)Nabriva Therapeutics AG2022-03-01
PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age) (NCT03709914)Nabriva Therapeutics AG2018-05-24
4-way Crossover QT Evaluation in Healthy Subjects (NCT03709927)Nabriva Therapeutics AG2018-01-11
A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781 (NCT03131141)Nabriva Therapeutics AG2017-01-08
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia (NCT02813694)Nabriva Therapeutics AG2016-08-01
Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections (NCT02753946)Nabriva Therapeutics AG2016-04-01
Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia (NCT02559310)Nabriva Therapeutics AG2015-09-01
Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects (NCT02557789)Nabriva Therapeutics AG2015-06-01
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) (NCT01119105)Nabriva Therapeutics AG2010-05-01

Track Nabriva Therapeutics AG automatically

Every clearance here is in the API, with alerts when new ones post.